conference

Interviews and expert commentary tagged “conference” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Audio Journal of Medicine
Audio Journal of Oncology

Audio Journal of Medicine

In this edition: 1. Training In Depression And Suicide: Need For Change? Stan Kutcher, Dalhousie University, Nova Scotia 2. Suicide Paradox Explained: Australian National Strategy Barry Nurcombe, Prin

20 May 2008
0:00
Audio Journal of Oncology Volume 16 Number 9
Audio Journal of Oncology

Audio Journal of Oncology Volume 16 Number 9

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam Angel Rod

26 April 2008
0:00
Audio Journal of Oncology in Advance – March 1st, 2008
Audio Journal of Oncology

Audio Journal of Oncology in Advance – March 1st, 2008

Volume 16 Number 5 (March 1st, 2008) reporting from: 4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris) Gastrointestinal Cancers Symposium (January 25-27, 2008, Orlando) A

4 March 2008
0:00
Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?
Audio Journal of Oncology

Radio-Labelled Antibodies: Big Benefits in Follicular Lymphoma?

Timothy Illidge Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008 TIMOTHY ILLIDGE, Christie Hospital, Manchester Radioconjugated antibodies are showing grea

27 February 2008
0:00
Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer
Audio Journal of Oncology

Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer

David Cunningham REFERENCE: Abstract 3012, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 DAVID CUNNINGHAM, Royal Marsden Hospital, London The oral agent capeticabine

15 February 2008
0:00
Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone
Audio Journal of Oncology

Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone

Cora Sternberg REFERENCE: Abstract 4010, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 CORA STERNBERG, San Camillo and Forlanini Hospital, Rome Satraplatin could pro

1 February 2008
0:00
Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer
Audio Journal of Oncology

Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer

Charles Hsu CHARLES HSU, Johns Hopkins University, Baltimore Big improvements in overall survival were achieved by combining radiation with adjuvant chemotherapy for patients with pancreas cancer in a

27 January 2008
0:00
Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Audio Journal of Oncology

Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Jean-Yves Douillard Gordon McVie REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 JEAN-YVES DOUILLARD, Centre René Gauducheau, N

16 November 2007
0:00
Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results
Audio Journal of Oncology

Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results

REFERENCE: Abstract: Late Breaking Clinical Trials, Session 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida LESLEE SHAW, Emory University, Atlanta COMMENT: DANI

5 November 2007
0:00
Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer
Audio Journal of Oncology

Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

Jose Baselga Gordon McVie REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona CO

16 October 2007
0:00
DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates
Audio Journal of Oncology

DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates

Pedro Cahn REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires Etraviri

21 September 2007
0:00
Hospital Hand Hygiene Program Successfully Rolled Out
Audio Journal of Oncology

Hospital Hand Hygiene Program Successfully Rolled Out

Lindsay Grayson REFERENCE: Abstract K-1374, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 LINDSAY GRAYSON, Austin Hospital, Victoria, Australia A

21 September 2007
0:00
Vancomycin: New Guidelines May Induce Kidney Damage
Audio Journal of Oncology

Vancomycin: New Guidelines May Induce Kidney Damage

Megan Nguyen REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 MEGAN NGUYEN, Western University in Pomona, Calif

19 September 2007
0:00
Virus Plus Cytokine Fight Primary and Metastatic Cancer
Audio Journal of Oncology

Virus Plus Cytokine Fight Primary and Metastatic Cancer

Paul Fisher REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles PAUL FISHER, Columbia University, New York Patients with cancer could soon be treated with adenoviruses capable of infecting b

15 August 2007
0:00
When Good Cells Go Bad: The Stem Cell Origin of Cancers
Audio Journal of Oncology

When Good Cells Go Bad: The Stem Cell Origin of Cancers

DAVID JABLONS, University of California, San Francisco REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain Cell signalling using the Wnt pathway may hold

16 March 2007
0:00
Audio Journal of Cardiovascular Medicine: September 7th 2006
Audio Journal of Oncology

Audio Journal of Cardiovascular Medicine: September 7th 2006

Gilles Montalescot Freek Verheugt Angioplasty: Four-Continent RIVIERA Study Identifies “Real World” Modifiable Factors Which Affect Outcome REFERENCE: Abstract 3413, “Hot Line II&rdq

7 September 2006
0:00